Second, IHC analysis of tissue samples from validation cohorts 1, 2, and 3 showed a substantial increase in NR4A2 protein abundance in ESCC tissues as relative to NATs (Fig. 7B, C, Supplementary Fig. S7A, B). This evidence concerns the gene NR4A2 and esophageal squamous cell carcinoma.